抗微生物暴露对帕金森病风险的影响
Gian Pal1, Laura Bennett2, Jason Roy3
1Department of Neurology, Rutgers-Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
Parkinsonism & related disorders
|August 4, 2024
概括
抗微生物暴露可能会影响帕金森病 (PD) 风险. 青素使用与较低的PD风险有关,而抗真菌剂暴露显示了PD风险的潜在增加.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 流行病学 流行病学
背景情况:
- 帕金森病 (PD) 是一种神经退行性疾病,具有复杂的病因.
- 抗微生物暴露在PD病原发生中的作用尚不清楚.
研究的目的:
- 调查抗微生物药物暴露与患帕金森病的风险之间的关联.
主要方法:
- 使用临床实践研究数据链接 (CPRD) 的嵌套病例控制研究.
- 匹配了12557个PD病例与80,804个对照.
- 在诊断前1-15年使用后勤回归和GEE分析了抗菌素处方.
主要成果:
- 多个青素疗程显示了与PD风险的逆剂量反应关系 (例如,OR 0.85,1-5年前).
- 麦克罗化物暴露与PD风险相反相关,但不显著.
- 在5年内暴露于≥2次抗真菌药物疗程与PD风险增加有关 (OR1.16).
结论:
- 青素的使用可能与帕金森病的风险略低有关.
- 抗真菌药物暴露可能与帕金森病的风险略高相关.
相关概念视频
Parkinson's Disease: Treatment
241
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
241
Parkinson's Disease: Overview
508
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
508
Drugs Affecting Neurotransmitter Synthesis
1.3K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.3K
Factors Affecting the Risk of Infection
11.5K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
11.5K
Neural Regulation
39.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.2K
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
541
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
541


